Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9051385
APP PUB NO 20100034842A1
SERIAL NO

12573685

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DENDREON PHARMACEUTICALS INC400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Diegel, Michael Covington, US 3 21
Graddis, Thomas Seattle, US 5 25
Laus, Reiner Bellevue, US 25 325
Vidovic, Damir Bellevue, US 8 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00